Daejeon, South Korea

Sang-Im Park

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang-Im Park. Retrieved from https://idiyas.com/inventor/sang-im-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Sang-Im Park

Introduction

Sang-Im Park is an accomplished inventor based in Daejeon, South Korea. He has made significant strides in the field of medical technology, particularly with his innovative approach to cancer treatment and diagnosis through the use of radioactive magnetic fluids.

Latest Patents

Sang-Im Park holds a patent for "Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof." This invention relates to the development of radioactive magnetic fluids that incorporate copper as a key component. These fluids emit beta and gamma radiation, which are not only capable of effectively killing tumor cells but also allow for easy imaging with gamma cameras. The innovation facilitates targeted treatment, minimizing side effects by concentrating the therapeutic effect on the tumor site through the use of an external magnetic field.

Career Highlights

Throughout his career, Sang-Im Park has demonstrated a commitment to addressing complex medical challenges. His research focuses on developing solutions that enhance the efficacy of cancer treatments while prioritizing patient safety and comfort. The tightly bonded layer of decanoic acid and nonanoic acid in his invention contributes to the stability and dispersion of magnetic nanoparticles in water, further advancing the potential of his magnetic fluids as therapeutic drugs or diagnostic reagents.

Collaborations

Sang-Im Park has collaborated with esteemed colleagues in his field, including Chong-Oh Kim and Jong-Hee Kim. Together, they have worked to refine and enhance the applications of innovative technologies within cancer treatment, combining their expertise to push the boundaries of what is possible in medical research.

Conclusion

Inventor Sang-Im Park's research into radioactive magnetic fluids represents a significant advancement in cancer treatment technologies. His contributions help pave the way for more effective and less invasive diagnostic and therapeutic options, embodying the spirit of innovation essential for progress in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…